2001

Dec 17, 2001
Guidant Announces Strategic Alliance with HeartCenterOnline

Internet Based Channel Provides Comprehensive Information for Heart Patients Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT) today announced a strategic partnership with...

Dec 11, 2001
Guidant Files with FDA for Next-Generation Intravascular Radiotherapy Systemment for High Surgical-Risk Patients

GALILEO III System Designed to Enable Physicians to More Easily and Precisely Treat Longer Heart Blockages Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a...

Dec 7, 2001
Guidant's New Defibrillator Manages Abnormal Heart Rates in Upper and Lower Chambers

European Market Release and U.S First Implant of Dual Chamber Defibrillator with Advanced Atrial Arrhythmia Management Indianapolis, Ind. and St. Paul, MN - Guidant Corporation (NYSE and PCX:...

Nov 27, 2001
Guidant Holds Conference Call to Review MADIT II Study

Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular disease, announced today that it will conduct a...

Nov 26, 2001
Guidant to Participate In Merrill Lynch Medical Technology Fundamentals Conference

Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular disease, announced today that it will...

Nov 20, 2001
Guidant Notified that Landmark Implantable Defibrillator Study Ends Early

MADIT II Study Stopped Due to 30 Percent Mortality Reduction in Heart Attack Survivors with Implantable Defibrillators Indianapolis, IN and St. Paul, MN - The MADIT II investigative team today...

Nov 14, 2001
Guidant Launches Advanced Stent System in Japan

New Technology Offering Provides Significant Benefit to Second Largest Coronary Stent Market in the World Indianapolis, Ind. and Tokyo, Japan. - Guidant Corporation (NYSE and PCX: GDT), a world...

Nov 13, 2001
Guidant Completes Enrollment Of First Drug-Eluting Stent Trial Utilizing Actinomycin-D

Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary artery disease, today announced that it has completed enrollment...

Nov 12, 2001
Results of Guidant's Next Generation Intravascular Radiotherapy System Clinical Trial Revealed

GALILEO INHIBIT Trial Presented Today at American Heart Association Meeting Indianapolis, Ind. and Anaheim, Calif. - The results of Guidant Corporation's (NYSE and PCX: GDT) GALILEO INHIBIT trial...

Nov 12, 2001
Guidant Commends Cook on Promising Results of Latest Paclitaxel-Coated Stent Trial

Indianapolis, Ind. and Anaheim, Calif. - Guidant Corporation (NYSE and PCX: GDT) congratulated Cook Incorporated on the announcement of Cook's highly positive results from its paclitaxel-coated...

Nov 9, 2001
Guidant and Cook Announce FDA Approval To Begin U.S. Clinical Trial With Paclitaxel-Coated Stent

First U.S. Patient Treated in Pivotal Clinical Trial Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT) and Cook Incorporated today announced Investigational Device Exemption (IDE)...

Nov 8, 2001
Guidant to Host Vascular Intervention Investor Briefing at AHA

Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular disease, announced today that it will host an...

Nov 7, 2001
Guidant and Merck KGaA Collaborate on Heart Failure Education

International Symposium Offers Unique Opportunity for Experts in Device Technology and Drug Therapy to Share Knowledge Indianapolis, IN - A major international heart failure symposium co-sponsored...

Nov 6, 2001
Guidant Announces First Human Implant of Newest Active-Fixation Defibrillation Lead

Defibrillation Lead Features Advances in Handling and Visibility for Ease in Positioning Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...

Nov 5, 2001
Guidant's Automated Radiotherapy Treatment for Coronary Artery Disease Receives FDA Approval

GALILEO System Sets New Standards of Precision and Ease of Use Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary...

Oct 18, 2001
Guidant Reports Record Third Quarter Sales of $662 Million

Double Digit Growth from Balanced Geographic Performance; Earnings Per Share Reach $0.40 Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in technology for the treatment...

Oct 15, 2001
Guidant Announces Live Webcast of Annual Analyst Meetin

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular disease, announced today that it will host its annual analyst meeting...

Oct 12, 2001
Guidant Launches Carotid Stent System in Europe

Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular disease, today announced that the company has...

Oct 11, 2001
Guidant Announces Live Webcast of its Third Quarter Earnings Conference Call

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular disease, will conduct a live webcast of its third quarter 2001 earnings...

Oct 10, 2001
Guidant Announces Worldwide Launch of New Product for Treating Peripheral Vascular Disease

Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT) today announced the global launch of its second-generation VIATRAC(tm) 14 PLUS Peripheral Dilatation Catheter...

Oct 9, 2001
Guidant Announces CE Mark Approval and First Implants of Advanced Pacemaker System

New Pacemaker Offers Advanced Therapy, Comprehensive Patient Management and Ease-of-Use Features Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...

Oct 8, 2001
Guidant and Cook Announce Submission of FDA filing to begin U.S. Drug-Coated Stent Trial

Indianapolis, Ind. and Bloomington, Ind. - Guidant Corporation (NYSE and PCX: GDT) and COOK Incorporated today announced that an investigational device exemption (IDE) application has been...

Sep 25, 2001
Guidant Appoints Ralph Hall Deputy General Counsel, Litigation and Compliance

Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT) today announced that Ralph Hall, currently secretary and general counsel, cardiac rhythm management, has been promoted...

Sep 21, 2001
Guidant Strengthens Cardiovascular Product Line by Entering New Segment of Guide Wire Market

Company Launches New Polymer Coated Guide Wire in the U.S. Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT) a world leader in the treatment of coronary artery...

Sep 19, 2001
Guidant Announces Significant Progress in its Multiple Programs for Drug-Coated Stents

Guidant Completes ACTION Clinical Trial Enrollment for FDA Filing; Company Confirms Submission of PMA Amendment for Heart Failure Technology Guidant Completes ACTION Clinical Trial Enrollment for...

Sep 17, 2001
Guidant Announces Market Release of its Most Advanced Pacemaker Systems in Japan

Several New Features Designed to Enhance Patient Management Indianapolis, IN and Tokyo, Japan - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and...

Sep 17, 2001
Guidant Expresses Support for the President and our Leaders

Patients Continue to Receive Medical Device Products on an Expedited Basis Indianapolis, Ind. - Ronald W. Dollens, president and CEO of Guidant Corporation (NYSE and PCX: GDT), expressing support...

Sep 11, 2001
Guidant Cancels Briefing at the Transcatheter Cardiovascular Therapeutics Conference

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT) announced today that it has cancelled its briefing at the Transcatheter Cardiovascular Therapeutics (TCT) conference in Washington,...

Sep 7, 2001
Guidant to Host Briefing at the Transcatheter Cardiovascular Therapeutics Conference

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the medical technology industry, will host a briefing at the Transcatheter Cardiovascular Therapeutics (TCT)...

Aug 23, 2001
Guidant Introduces Next Generation Radiotherapy System Outside of the United States

Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT) announced today that it has received European CE Mark approval of its next generation radiotherapy system. This...

Aug 22, 2001
Nicky Spaulding Promoted to Guidant Management Committee as President, Cardiac Surgery

Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT) announced today that Nicky Spaulding has been promoted to the Guidant Management Committee as president of the...

Aug 20, 2001
Guidant Elaborates on its Distribution Agreement with COOK

Agreement Intended to Accelerate Time to Market and Complements Guidant's Drug-Coated Stent Program. Guidant Announces Live Webcast of its Drug-Coated Stent Briefing Indianapolis, Ind. - Guidant...

Aug 17, 2001
Guidant Receives Approval for Full Market Release of ANCURE System

Less-Invasive Therapy Available to Treat Patients with Abdominal Aortic Aneurysms Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...

Aug 17, 2001
Guidant Appoints Debra F. Minott as Vice President, General Counsel and Secretary

Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT) today announced that Debra F. Minott, currently deputy general counsel and secretary, Guidant, has been promoted to vice president,...

Aug 15, 2001
First Patients Treated with Guidant's Next Generation Coronary Stent

Latest Stent Constructed of New Material Designed to Enhance Performance Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...

Aug 10, 2001
Appellate Court Decision Affirms the Strength of Guidant's Coronary Stent Patents

Indianapolis, Ind. - Guidant Corporation today stated that a recent U.S. Court of Appeals ruling on a coronary stent patent infringement suit affirms the strength of specific Guidant coronary...

Jul 24, 2001
Guidant Announces Worldwide Launch of New Self-Expanding Stent System

New Product Introduction Broadens Guidant's Global Line of Non-Coronary Therapies Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT) today announced the global...

Jul 18, 2001
Guidant Introduces its New Generation of Heart Failure Therapy

European Market Release of CONTAK RENEWAL, First Human Use Worldwide of CONTAK RENEWAL 2 Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT) today announced European market...

Jul 17, 2001
Guidant Reports Second Quarter Sales of $656 Million

Earnings per share reach $0.38. Double-digit sales growth projected for the third and fourth quarters. Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in technology for...

Jul 17, 2001
Physicians Resume Implants with Guidant's ANCURE System

Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, announced today that it has received an...

Jul 13, 2001
Guidant Revises Schedule for Second Quarter Earnings Release and Conference Call

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT) today announced that it has revised the schedule for the company's second quarter earnings press release and conference call from...

Jul 13, 2001
Guidant Corporation Meets With the FDA on CONTAK CD/EASYTRAK System

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT) and the U.S. Food and Drug Administration today met to identify next steps following the recent FDA Circulatory Systems Devices...

Jul 10, 2001
FDA Advisory Committee Elects Not To Recommend Guidant's CONTAK CD for Approval

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), today reported that the Circulatory Systems Device Panel of the U.S. Food and Drug Administration (FDA) elected not to recommend...

Jul 9, 2001
Guidant Receives FDA Approval of First Stent Designed Exclusively for Small Vessels in Patients Presenting with Abrupt and Threatened Abrupt Closure

Stent's Performance in Europe Supports Growth in Guidant's Stent Market Position Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT) today announced that it has...

Jun 19, 2001
Guidant Receives FDA Clearance for New Biliary Stent System

New Product Offering Further Expands Guidant's Stent Product Line Indianapolis, Ind. and Menlo Park, Calif - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...

Jun 5, 2001
Guidant Receives European Approval to Treat Long Coronary Blockages with Radiotherapy

Approval Will Allow Physicians to Treat a Greater Number of Patients Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...

Jun 4, 2001
Guidant Corporation to Donate $1 Million in Medical Technology to the Larry King Cardiac Foundation

Donation to help low-income individuals receive life-saving cardiac therapies LOS ANGELES, CA - During the Larry King Cardiac Foundation fundraiser, "An Evening with Larry King and Friends,"...

May 24, 2001
First Patients Treated With Guidant's Drug-Eluting Stent

Clinical Trial Will Be Basis for CE Mark Approval of MULTI-LINK TETRA-D(tm) Stent Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...

May 23, 2001
Guidant Announces CE Mark Approval and First European Implant of Next-Generation Heart Failure Technology

New Device Includes Diagnostic Capabilities for Better Patient Management Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT) today announced European CE Mark approval of...

May 22, 2001
Guidant Unveils Latest Coronary Stent Technology in Europe

Company Launches MULTI-LINK PENTA Stent Indianapolis, Ind. and Santa Clara, Calif. - Physicians in Europe are getting a glimpse at the latest coronary stent technology, following the European...

Show 5102550100 per page
Top